Hudson Frederick M. 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Hudson Frederick M.
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-09$12.98/sh+15,000$194,700→ 61,307 total - Exercise/Conversion
Director Stock Option (Right to Buy)
2026-01-09−15,000→ 0 totalExercise: $12.98From: 2017-03-01Exp: 2026-03-01→ Common Stock (15,000 underlying)
Signature
/s/ Timothy C. Dec, as attorney-in-fact|2026-01-12